A dynamic visualization clinical tool constructed and validated based on the SEER database for screening the optimal surgical candidates for bone metastasis in primary kidney cancer

• Published in: Scientific reports Vol. 14; no. 1; p. 3561
• Main Authors: Jiang, Liming, Tong, Yuexin, Wang, Jun, Jiang, Jiajia, Gong, Yan, Zhu, Dejin, Zheng, Linyang, Zhao, Dongxu
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 12.02.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67/1344; 631/67/2322; 631/67/2324; 631/67/322; 631/67/589; 631/67/70; 692/308; 692/4022; 692/4025; 692/4028; 692/499; 692/699; Bone cancer; Bone metastasis; Epidemiology; Humanities and Social Sciences; Kidney cancer; Kidneys; Metastases; Metastasis; multidisciplinary; Nomograms; Optimal surgical candidates; Patients; Primary tumor resection; Regression analysis; Risk factors; Science; Science (multidisciplinary); SEER database; Survival; Survival analysis; Bone metastasis; SEER database; Optimal surgical candidates; Kidney cancer; Primary tumor resection
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-54085-x

The implementation of primary tumor resection (PTR) in the treatment of kidney cancer patients (KC) with bone metastases (BM) has been controversial. This study aims to construct the first tool that can accurately predict the likelihood of PTR benefit in KC patients with BM (KCBM) and select the optimal surgical candidates. This study acquired data on all patients diagnosed with KCBM during 2010–2015 from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM) was utilized to achieve balanced matching of PTR and non-PTR groups to eliminate selection bias and confounding factors. The median overall survival (OS) of the non-PTR group was used as the threshold to categorize the PTR group into PTR-beneficial and PTR-Nonbeneficial subgroups. Kaplan–Meier (K–M) survival analysis was used for comparison of survival differences and median OS between groups. Risk factors associated with PTR-beneficial were identified using univariate and multivariate logistic regression analyses. Receiver operating characteristic (ROC), area under the curve (AUC), calibration curves, and decision curve analysis (DCA) were used to validate the predictive performance and clinical utility of the nomogram. Ultimately, 1963 KCBM patients meeting screening criteria were recruited. Of these, 962 patients received PTR and the remaining 1061 patients did not receive PTR. After 1:1 PSM, there were 308 patients in both PTR and non-PTR groups. The K–M survival analysis results showed noteworthy survival disparities between PTR and non-PTR groups, both before and after PSM (p < 0.001). In the logistic regression results of the PTR group, histological type, T/N stage and lung metastasis were shown to be independent risk factors associated with PTR-beneficial. The web-based nomogram allows clinicians to enter risk variables directly and quickly obtain PTR beneficial probabilities. The validation results showed the excellent predictive performance and clinical utility of the nomograms for accurate screening of optimal surgical candidates for KCBM. This study constructed an easy-to-use nomogram based on conventional clinicopathologic variables to accurately select the optimal surgical candidates for KCBM patients.